SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001213900-20-011910
Filing Date
2020-05-13
Accepted
2020-05-13 08:49:10
Documents
52
Period of Report
2020-03-31

Document Format Files

Seq Description Document Type Size
1 QUARTERLY REPORT f10q0320_delmarpharma.htm 10-Q 607192
2 CERTIFICATION f10q0320ex31-1_delmar.htm EX-31.1 14759
3 CERTIFICATION f10q0320ex31-2_delmar.htm EX-31.2 14403
4 CERTIFICATION f10q0320ex32-1_delmar.htm EX-32.1 5813
5 CERTIFICATION f10q0320ex32-2_delmar.htm EX-32.2 5799
6 GRAPHIC image_01.jpg GRAPHIC 33104
  Complete submission text file 0001213900-20-011910.txt   3408039

Data Files

Seq Description Document Type Size
7 XBRL INSTANCE FILE dmpi-20200331.xml EX-101.INS 629401
8 XBRL SCHEMA FILE dmpi-20200331.xsd EX-101.SCH 48088
9 XBRL CALCULATION FILE dmpi-20200331_cal.xml EX-101.CAL 33374
10 XBRL DEFINITION FILE dmpi-20200331_def.xml EX-101.DEF 163434
11 XBRL LABEL FILE dmpi-20200331_lab.xml EX-101.LAB 301682
12 XBRL PRESENTATION FILE dmpi-20200331_pre.xml EX-101.PRE 227970
Mailing Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130
Business Address 12707 HIGH BLUFF DR., SUITE 200 SAN DIEGO CA 92130 (858) 350-4364
DelMar Pharmaceuticals, Inc. (Filer) CIK: 0001498382 (see all company filings)

IRS No.: 990360497 | State of Incorp.: NV | Fiscal Year End: 0630
Type: 10-Q | Act: 34 | File No.: 001-37823 | Film No.: 20871189
SIC: 2834 Pharmaceutical Preparations